El interés en corto de HCW Biologics da a los inversores una idea del grado en que los inversores apuestan por la caída de las acciones de HCW Biologics. Los datos de interés en corto se actualizan cada dos semanas.

HCW Biologics (NASDAQ:HCWB) Bolsa, Informe de interés en corto

HCW Biologics

HCW Biologics Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen the health span by disrupting the link between chronic, low-grade inflammation and age-related diseases. The company has developed TOBI discovery platform, or Tissue factor-based fusion discovery platform, for the design of category-defining immunotherapeutic drugs. It has selected two molecules as its product candidate; HCW9218 and HCW9302. HCW9218 is a bifunctional immunotherapeutic designed with the capabilities to neutralize transforming growth and stimulate immune cells. HCW9302 is designed to activate and expand regulatory T cells, which deactivate inflammasomes.

HCW Biologics Inc

Sen. Chuck Schumer (D-N.Y.) tore into Donald Trump&#8217;s alleged &#8220;side deal&#8221; with Iran on Monday and demanded that the president make public any such agreements with Tehran.
What Happened: Schumer took to X to criticise Trump, Secretary of State Marco Rubio and United States Special Envoy to the Middle East Steve Witkoff. 
He said, &#8220;If TACO Trump is already folding on Iran, the American people need to know about it.&#8221; TACO refers to a <a href="https://www.benzinga.com/25/05/45665026/trump-always-chickens-out-president-confronted-with-taco-trade-thesis-by-reporteras-markets-bet-hell-blink-again">Wall Street trade</a> premised on the idea that the president always backs away from his earlier aggressive stances. It&#8217;s an acronym for &#8220;Trump Always Chickens Out.&#8221;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">If TACO Trump is already folding on Iran, the American people need to know about it. No side deals. <a href="https://t.co/T4gnekrGhT">pic.twitter.com/T4gnekrGhT</a>
&mdash; Chuck Schumer (@SenSchumer) <a href="https://twitter.com/SenSchumer/status/1929676991789203528?ref_src=twsrc%5Etfw">June 2, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Schumer said Trump was &#8220;all over the lot&#8221; when it came to negotiating with Iran, in a video he attached to his post. &#8220;One day, he sounds tough, the next day he&#8217;s backing off.&#8221; The Senate minority leader said that it&#8217;s become public that Rubio and Witkoff are negotiating a &#8220;secret side deal&#8221; with Iran.
&#8220;They&#8217;re gonna sound tough in public and then and then have a side deal that lets Iran get away with everything? That&#8217;s outrageous,&#8221; said Schumer. He then went on to demand that such a deal be put before the American people and the Congress.
The United States has reportedly put forward a nuclear proposal to Iran, permitting limited low-level uranium enrichment within the country. This move marks a departure from previous public statements by U.S. officials advocating for zero enrichment.
The proposal, <a href="https://www.axios.com/2025/06/02/iran-nuclear-deal-proposal-enrich-uranium">reported</a> by Axios, was delivered by Witkoff. It includes preliminary ideas for the upcoming round of nuclear talks. The plan suggests that Iran dismantle key nuclear infrastructure and cease new centrifuge research. Additionally, it proposes a regional enrichment consortium, limiting Iran&#8217;s domestic capabilities to civilian purposes.
This proposal has raised concerns among U.S. allies, particularly Israel and Republican senators, who have consistently advocated for zero enrichment and the complete dismantlement of Iran&#8217;s nuclear program. Axios reported that Prime Minister Benjamin Netanyahu has been pushing for a stringent deal and cautioned against actions that might jeopardize negotiations.
See Also: <a href="https://benzinga.com/markets/economic-data/25/06/45715685/howard-lutnick-calls-1-2-trillion-trade-deficit-a-national-emergency-says-trumps-tariffs-ar" target="_blank" rel="noreferrer noopener">Howard Lutnick Calls $1.2 Trillion Trade Deficit A &#8216;National Emergency,&#8217; Says Trump&#8217;s Tariffs Are &#8216;Not Going Away&#8217;</a>
Meanwhile, Trump took to social media to deny that the administration would allow Iran to enrich Uranium.
<figure class="wp-block-image size-full"><img loading="lazy" decoding="async" width="606" height="198" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/02203907/Screenshot-2025-06-03-at-9.38.51.png" alt="" class="wp-image-935764" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/02203907/Screenshot-2025-06-03-at-9.38.51.png 606w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/06/02203907/Screenshot-2025-06-03-at-9.38.51-300x98.png 300w" sizes="(max-width: 606px) 100vw, 606px" /></figure>
Screenshot from President Donald Trump&#8217;s Truth Social Account
Why It Matters: In April 2025, Iran signaled its willingness to engage in high-level nuclear discussions with the U.S., while warning against <a href="https://www.benzinga.com/news/25/04/44758747/iran-signals-openness-to-nuclear-talks-with-us-warns-against-trumps-aggressive-theatrics">Trump&#8217;s aggressive theatrics</a>.
The latest proposal comes after a series of diplomatic gestures and tensions between the U.S. and Iran. In May 2025, Trump <a href="https://www.benzinga.com/25/05/45395894/trump-makes-peace-gesture-at-iran-amid-middle-east-optimism-willing-to-end-past-conflicts-and-forge-new-partnerships">extended an olive branch</a> to Iran, expressing hope for improved relations in the Middle East. This was part of a broader strategy to be perceived as a global peacemaker.
Trump had earlier reinstated his &#8220;maximum pressure&#8221; sanctions campaign on Iran, <a href="https://www.benzinga.com/25/02/43480859/trump-confirms-maximum-economic-pressure-on-iran-calls-chinas-tariff-retaliation-fine">aiming to increase economic and political pressure</a> on Tehran. This dual approach of pressure and diplomacy has characterized the U.S.-Iran relations under Trump&#8217;s administration.
Photo Courtesy: Bumble Dee On Shutterstock.com
Check This Out:
<ul class="wp-block-list">
<li>Lawmakers Made Huge Investments This Year. <a href="https://www.benzinga.com/gov-trades">Get Tips On What They Bought And Sold Ahead Of The 2024 Election With Our Easy-to-Use Tool</a></li>
</ul>
This story was generated using <a href="https://www.benzinga.com/author/benzinga-neuro">Benzinga Neuro</a> and edited by <a href="https://www.benzinga.com/author/shivdeep-dhaliwal" target="_blank" rel="noreferrer noopener">Shivdeep Dhaliwal</a>

News

Politics

General

Chuck Schumer Says If 'TACO Trump' Is Already Folding On Iran The American People Need To Know: 'One Day, He Sounds Tough, The Next Day He's Backing Off'

Salesforce (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRM#NYSE">CRM</a>) <a href="https://www.salesforce.com/news/press-releases/2025/05/27/salesforce-signs-definitive-agreement-to-acquire-informatica/">announced</a> Tuesday that it will acquire Informatica (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/INFA#NYSE">INFA</a>) in a cash deal valued at approximately $8 billion. The acquisition underscores Salesforce's intent to bolster its artificial intelligence capabilities by integrating a core player in enterprise data management.
Under the terms of the deal, holders of Informatica's Class A and Class B-1 common stock will receive $25 per share — an 11% premium over the company's closing price of $22.55 on Friday, <a href="https://techcrunch.com/2025/05/27/salesforce-acquires-informatica-for-8-billion/">TechCrunch</a> reported.
Don't Miss:
<ul class="wp-block-list">
<li>Hasbro, MGM, and Skechers trust this AI marketing firm — <a href="https://www.benzinga.com/money/rad-intel">Invest before it's too late.</a></li>
<li>Invest where it hurts — and help millions heal:<a href="https://www.benzinga.com/money/a-cure-for-osteoarthritis-powered-by-everyday-investors-cytonics-is-looking-to-beat-big-pharma-and-disrupt-a-390-billion-market"> Invest in Cytonics and help disrupt a $390B Big Pharma stronghold</a>.</li>
</ul>
<h2 class="wp-block-heading">Informatica: &#8216;The Plumbing For AI&#8217;</h2>
Informatica CEO Amit Walia framed the acquisition as a shared effort to bring data and AI to life, describing Informatica in a statement as the plumbing for AI and data. Informatica's Intelligent Data Management Cloud platform helps enterprises connect, manage, and unify complex data systems across multi-cloud and hybrid environments.
"Joining forces with Salesforce represents a significant leap forward in our journey," Walia said in a statement on Tuesday. "We have a shared vision for how we can help organizations harness the full value of their data in the AI era."
Steve Fisher, Salesforce's chief technology officer, said that the truly autonomous, trustworthy AI agents need the most comprehensive understanding of their data, adding that Informatica's metadata and catalog tools will complement Salesforce's agentic AI platform, Agentforce.
Trending: <a href="https://www.benzinga.com/money/this-ai-imaging-technology-has-been-used-in-more-than-500-surgeries-now-you-can-be-part-of-the-ai-imaging-revolution">Be part of the next med-tech breakthrough for only $350 — 500+ surgeries already done with nView's AI system.</a>
<h2 class="wp-block-heading">Strategic Rationale: Building A Foundation For Agentic AI</h2>
The acquisition builds on Salesforce's previous investments in data and AI. It follows the company's multibillion-dollar acquisitions of Slack at $27.7 billion in 2021, Tableau at $15.7 billion in 2019, and MuleSoft at $6.5 billion in 2018.&nbsp;
According to Salesforce CEO Marc Benioff, Informatica will be integrated alongside Data Cloud, Tableau, and MuleSoft to enable autonomous agents to deliver smarter, safer, and more scalable outcomes for every company.
Salesforce&#8217;s operating and financial chief Robin Washington said the company will move quickly to leverage Informatica's capabilities across public sector, life sciences, healthcare, and financial services verticals, where governed, trustworthy data is critical.
The deal is expected to close in early fiscal 2027, pending regulatory approvals and other customary closing conditions.
See Also: <a href="https://www.benzinga.com/money/are-you-rich">Are you rich?</a> Here&#8217;s what Americans think you need to be considered wealthy.
<h2 class="wp-block-heading">From Buyout To Buy-In</h2>
Informatica was taken private in 2015 through a $5.3 billion deal led by private-equity firm Permira and the Canada Pension Plan Investment Board. Informatica says it serves more than 5,000 customers across nearly 100 countries, including over 80 of the Fortune 100, according to its acquisition announcement.
The transaction will be financed through a combination of Salesforce's cash and new debt, the company said in the announcement.&nbsp;
Read Next: How do billionaires pay less in income tax than you?<a href="https://www.benzinga.com/money/tax-deferring-adv"> Tax deferring is their number one strategy</a>.
Image: Shutterstock

INFA

Why Salesforce Is Paying $8 Billion for 'the Plumbing of AI'

SPYQ

Trading Halt: Halted at 7:50:00 p.m. ET - Trading Halt: Halt News Pending

QQQP

AGMH

MQQQ

Palo Alto Networks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PANW#NASDAQ">PANW</a>) has outperformed the market over the past 10 years by 10.11% on an annualized basis producing an average annual return of 21.13%. Currently, Palo Alto Networks has a market capitalization of $129.80 billion. 
Buying $100 In PANW: If an investor had bought $100 of PANW stock 10 years ago, it would be worth $676.52 today based on a price of $194.66 for PANW at the time of writing.
<h3>Palo Alto Networks's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1748907919_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

PANW

Here's How Much $100 Invested In Palo Alto Networks 10 Years Ago Would Be Worth Today

ON Semiconductor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ON#NASDAQ">ON</a>) has outperformed the market over the past 5 years by 2.94% on an annualized basis producing an average annual return of 16.11%. Currently, ON Semiconductor has a market capitalization of $17.84 billion. 
Buying $100 In ON: If an investor had bought $100 of ON stock 5 years ago, it would be worth $224.13 today based on a price of $42.70 for ON at the time of writing.
<h3>ON Semiconductor's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1748907012_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

If You Invested $100 In This Stock 5 Years Ago, You Would Have This Much Today

Booking Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BKNG#NASDAQ">BKNG</a>) has outperformed the market over the past 15 years by 13.7% on an annualized basis producing an average annual return of 25.82%. Currently, Booking Holdings has a market capitalization of $180.24 billion. 
Buying $100 In BKNG: If an investor had bought $100 of BKNG stock 15 years ago, it would be worth $3,140.15 today based on a price of $5538.91 for BKNG at the time of writing.
<h3>Booking Holdings's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1748906116_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BKNG

$100 Invested In Booking Holdings 15 Years Ago Would Be Worth This Much Today

Morgan Stanley (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MS#NYSE">MS</a>) has outperformed the market over the past 10 years by 1.6% on an annualized basis producing an average annual return of 12.62%. Currently, Morgan Stanley has a market capitalization of $205.99 billion. 
Buying $100 In MS: If an investor had bought $100 of MS stock 10 years ago, it would be worth $328.47 today based on a price of $128.40 for MS at the time of writing.
<h3>Morgan Stanley's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1748905215_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Here's How Much You Would Have Made Owning Morgan Stanley Stock In The Last 10 Years

Warren Buffett's investment in Coca-Cola Co. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KO#NYSE">KO</a>) is a master class in patient, long-term investing — and it pays him handsomely <a href="https://www.benzinga.com/24/11/42115069/warren-buffett-is-set-to-collect-776-million-in-coca-cola-dividends-but-daughter-says-his-wife-buys-him-the-soda-on-sale">every single day.</a>
What To Know: In 1988, Buffett began buying shares of Coca-Cola in the aftermath of the 1987 stock market crash and ultimately amassed 400 million shares through his company Berkshire Hathaway, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRK#NYSE">BRK</a>) (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BRK#NYSE">BRK</a>). 
The company's stake in Coca-Cola represents more than 10% of Berkshire&#8217;s portfolio and about 8% of Coca-Cola's outstanding shares. 
Read Next: <a href="https://www.benzinga.com/analyst-stock-ratings/price-target/25/06/45727360/amazon-analyst-sees-robotics-unlocking-billions-in-savings?utm_source=articleShare">Amazon Analyst Sees Robotics Unlocking Billions In Savings</a>
Fast forward to 2025, and those 400 million shares are worth over $25 billion — but the real magic is in the dividends. 
Coca-Cola pays shareholders a<a href="https://www.benzinga.com/quote/KO/dividends"> quarterly dividend</a> of 51 cents per share, amounting to $2.04 per share annually. Warren Buffett's Berkshire Hathaway is set to earn $816 million in Coca-Cola dividends in 2025.&nbsp;
Broken down, that's about $2.23 million flowing into Berkshire's coffers every single day, or nearly $93,000 per hour.&nbsp;
What Else: Buffett is well known for drinking Coke and has <a href="https://www.benzinga.com/personal-finance/25/01/43341020/warren-buffett-would-give-up-a-year-of-his-life-to-eat-whatever-he-wants-his-daughter-confirms-he-still-gets-daily-mcdonalds-breakfast-at-94">said he drinks</a> about five cans a day, even at age 94.&nbsp;
In 2015, he joked to Fortune, &#8220;I&#8217;m one-quarter Coca-Cola,&#8221; admitting that <a href="https://www.benzinga.com/personal-finance/24/09/40971688/warren-buffett-owns-28b-in-coca-cola-stock-and-drinks-5-cans-a-day-i-dont-think-the-prostate-can">the drink accounts</a> for 25% of his daily calorie intake.&nbsp;
As he famously quipped, "If you aren't willing to own a stock for 10 years, don't even think about owning it for 10 minutes." 
For Buffett, Coca-Cola has been a sweet investment — one that pays, quite literally, every single day.
Read Next:&nbsp;
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/news/space/25/06/45724938/space-stocks-weekly-countdown-rocketlab-gets-analyst-love-while-virgin-galactic-slides-into-june?utm_source=articleShare">Space Stocks Weekly Countdown: RocketLab Gets Analyst Love While Virgin Galactic Slides Into June</a></li>
</ul>
Image created using artificial intelligence via Midjourney.

Equities

Movers & Shakers

Success Stories

Markets

Warren Buffett Makes Over $2.2 Million A Day From This Stock

argenx (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARGX#NASDAQ">ARGX</a>) has outperformed the market over the past 5 years by 7.77% on an annualized basis producing an average annual return of 20.94%. Currently, argenx has a market capitalization of $35.06 billion. 
Buying $1000 In ARGX: If an investor had bought $1000 of ARGX stock 5 years ago, it would be worth $2,528.02 today based on a price of $574.14 for ARGX at the time of writing.
<h3>argenx's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1748904316_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

ARGX

$1000 Invested In This Stock 5 Years Ago Would Be Worth This Much Today

When it comes to personal finance, Kevin O&#8217;Leary isn&#8217;t sugarcoating anything. The &#8220;Shark Tank&#8221; investor is once again calling out high-interest <a href="https://www.benzinga.com/news/25/04/44889438/survey-unveils-american-misconceptions-about-credit-card-debt-management">credit card debt</a> and urging people to make getting out of it a top priority.
<h2 class="wp-block-heading">Debt Takes You Down</h2>
&#8220;The reason I own all the credit card companies is I&#8217;m getting paid 23% by people that have credit balances on their cards,&#8221; O&#8217;Leary said in a recent <a href="https://x.com/kevinolearytv/status/1927356996786786449">post on X</a>. &#8220;It&#8217;s crazy that you would pay interest of 23% on what you owe the credit card company.&#8221;
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">The reason I own all the credit card companies is I&#39;m getting paid 23% by people that have credit balances on their cards. It&#39;s crazy that you would pay interest of 23% on what you owe the credit card company. You should pay off your balance there and then retire all your debt… <a href="https://t.co/6O1rIO0pQQ">pic.twitter.com/6O1rIO0pQQ</a>
&mdash; Kevin O&#39;Leary aka Mr. Wonderful (@kevinolearytv) <a href="https://twitter.com/kevinolearytv/status/1927356996786786449?ref_src=twsrc%5Etfw">May 27, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Don't Miss:
<ul class="wp-block-list">
<li>Hasbro, MGM, and Skechers trust this AI marketing firm — <a href="https://www.benzinga.com/money/rad-intel">Invest before it's too late.</a></li>
<li>Invest where it hurts — and help millions heal:<a href="https://www.benzinga.com/money/a-cure-for-osteoarthritis-powered-by-everyday-investors-cytonics-is-looking-to-beat-big-pharma-and-disrupt-a-390-billion-market"> Invest in Cytonics and help disrupt a $390B Big Pharma stronghold</a>.</li>
</ul>
In an interview clip shared with the post, he went further: &#8220;You should pay off your balance there and then retire all your debt and start saving, even if you&#8217;re 30 or 40. You&#8217;d be amazed the <a href="https://www.benzinga.com/general/market-summary/25/05/45490762/charlie-munger-once-said-the-first-rule-of-compounding-is-to-never-interrupt-it-unnecessarily-now-his-wisdom-rings-true-as-the-sp-500-surges-220-over-10-years">power of compounding interest</a> over even a decade. It&#8217;s never too late. The key to life is stay out of debt.&#8221;
O&#8217;Leary also said credit card debt &#8220;comes out of nowhere and bites you&#8221; when you&#8217;re not ready. He called it &#8220;the <a href="https://www.benzinga.com/news/25/02/43424608/21-interest-rates-youve-got-to-be-kidding-me-kevin-oleary-slams-credit-card-debt-as-the-real-silent-killer-in-america">real silent killer</a> in America&#8221; in a separate <a href="https://x.com/kevinolearytv/status/1883537883501310043">interview</a> with WNYW-TV&#8217;s &#8220;Good Day New York,&#8221; emphasizing that most people don&#8217;t even realize how much they&#8217;re overspending.
His advice is to keep it simple: &#8220;Take a piece of paper, you don't need a computer, write down the money you made in 90 days and how much you spent during that same period.&#8221;
Trending: Maximize saving for your retirement and cut down on taxes: <a href="https://www.benzinga.com/money/wideradvisor-retirement-planning">Schedule your free call with a financial advisor to start your financial journey – no cost, no obligation</a>.&nbsp;
The reality for many, he says, is that they&#8217;re spending more than they earn. And what makes up the gap? Credit cards, with interest rates now averaging around 21%.
U.S. consumers hold $1.18 trillion in credit card debt in Q1, according to the <a href="https://www.newyorkfed.org/microeconomics/hhdc">Federal Reserve Bank of New York</a>. Balances fell by $29 billion from the previous quarter.
Billionaire Mark Cuban <a href="https://www.benzinga.com/personal-finance/24/05/39092288/if-you-use-your-credit-card-you-do-not-want-to-be-rich-warns-mark-cuban-on-the-dave-ramsey-show">shares the same view</a>. &#8220;If you use your credit cards, you do not want to be rich,&#8221; he told Dave Ramsey on &#8220;<a href="https://www.youtube.com/watch?v=KA0IUaoXSew">The Ramsey Show</a>.&#8221; Cuban suggests paying them off and getting rid of them completely. &#8220;If you pay that down you just earned 15 or 20%,&#8221; he said. Ramsey added that 75% of wealthy people make staying out of debt a top priority.&nbsp;
O&#8217;Leary insists it comes down to buying only what you can truly afford. He used his watches as an example: &#8220;This is a priceless Rolex&#8230; probably worth $150,000. Here&#8217;s a $300 Timex. Why do I wear them both? Two different time zones, but also this is a beautiful dial for 300 bucks.&#8221;
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/money/this-ai-imaging-technology-has-been-used-in-more-than-500-surgeries-now-you-can-be-part-of-the-ai-imaging-revolution">Be part of the next med-tech breakthrough for only $350 — 500+ surgeries already done with nView's AI system.</a></li>
<li>Many are using retirement income calculators to check if they&#8217;re on pace —<a href="https://www.benzinga.com/money/how-do-i-calculate-my-retirement-income-adv"> here&#8217;s a breakdown on what&#8217;s behind this formula.</a></li>
</ul>
Image: Shutterstock

Personal Finance

Kevin O'Leary Says 'It's Crazy' To Pay 23% Interest On Credit Card Debt. Here's What He Thinks 'The Key To Life' Is

Guidewire Software (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GWRE#NYSE">GWRE</a>) has outperformed the market over the past 10 years by 4.59% on an annualized basis producing an average annual return of 15.6%. Currently, Guidewire Software has a market capitalization of $18.05 billion. 
Buying $1000 In GWRE: If an investor had bought $1000 of GWRE stock 10 years ago, it would be worth $4,273.18 today based on a price of $215.24 for GWRE at the time of writing.
<h3>Guidewire Software's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1748903412_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

GWRE

Here's How Much $1000 Invested In Guidewire Software 10 Years Ago Would Be Worth Today

Afya Limited (NASDAQ:<a href="https://www.benzinga.com/stock/AFYA#NASDAQ">AFYA</a>, B3: A2FY34)) ("Afya" or the "Company"), the leading medical education group and medical practice solutions provider in Brazil, announced today that its board of directors (the "Board"), following the recommendation of the Board's audit committee, recently approved the engagement of KPMG Auditores Independentes Ltda. ("KPMG") to provide independent auditing services for the Company, replacing Ernst &amp; Young Auditores Independentes S/S Ltda., as its independent registered public accounting firm.
KPMG will commence its activities with the review of our quarterly information for the second quarter of 2025.

Management

AFYA

Afya Limited's Board Approves Engagement Of KPMG As New Independent Auditor

Electric vehicle leader Tesla Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) is continuing to see large declines in deliveries in many territories around the world, with data from Europe <a href="https://www.benzinga.com/markets/eurozone/25/05/45616006/teslas-european-woes-see-no-end-april-sales-crash-49-as-rivals-race-ahead-in-ev-market">looking particularly bad.</a>
What Happened: Items such as <a href="https://www.benzinga.com/news/earnings/25/04/44937440/tesla-q1-misses-estimates-as-tariff-pressures-weigh-on-outlook-lower-cost-evs-still-on-track">tariffs and macroeconomic concerns</a> could hurt Tesla's delivery figures in the U.S. and other parts of the world.
Europe might be the market Tesla is struggling with the most, which comes as other competitors are outperforming it. The Elon Musk-led company also suffered brand damage in 2024 and 2025 due to the CEO's political involvement in several countries&#8217; <a href="https://www.nbcnews.com/tech/elon-musk/elon-musk-boosting-far-right-politics-globe-rcna189505">elections</a>.
A new report shared by <a href="https://electrek.co/2025/06/02/tesla-sales-crash-france-even-with-new-model-y/">Electrek </a>said Tesla's deliveries in France were 721 units in May. This figure was down 67% year-over-year and is the lowest for the country in over three years.
The overall automotive market was down 12% year-over-year for France in May, but companies outside of Tesla saw much better results.
The report on the struggles in France comes as a recent ACEA report said Tesla's European sales were down 49% year-over-year in April.
Read Also: <a href="https://www.benzinga.com/news/25/05/45681831/is-tesla-insurance-losing-money-new-report-says-business-not-sustainable">Is Tesla Insurance Losing Money? New Report Says Business Not Sustainable</a> 
Why It's Important: Musk insisted that Tesla has "no demand problem" and everything is going fine. Recent delivery reports for regions around the world suggest otherwise and could put second-quarter deliveries in the spotlight.
Tesla placed a portion of its weaker sales blame on the Model Y changeover. May sales for Tesla in France were lower than any month in the first quarter, when the Model Y changeover was happening. With the changeover now complete in some parts of the world, weak second-quarter data shows that this may not have been the reason for weaker demand.
While France represents only one market for Tesla, the May data is bad and could be another negative for second-quarter deliveries and financial results.
TSLA Price Action: Tesla stock closed Monday down 1.09% to $342.69 versus a 52-week trading range of $167.42 to $488.54. Tesla stock is down around 15% year-to-date in 2025.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/general/space/25/05/45680115/tesla-the-best-elon-musk-company-84-say-no-these-3-rank-higher">Tesla The Best Elon Musk Company? 84% Say No — These 3 Rank Higher</a></li>
</ul>
Photo: Shutterstock

Eurozone

TSLA

Tesla Sales Hit 3-Year Low In This European Nation Despite Musk's Claims Of 'No Demand Problem'

<a href="https://truthsocial.com/@realDonaldTrump/114616038217949758">https://truthsocial.com/@realDonaldTrump/114616038217949758</a>

President Trump Posts On Truth Social "The AUTOPEN should have stopped Iran a long time ago from "enriching." Under our potential Agreement — WE WILL NOT ALLOW ANY ENRICHMENT OF URANIUM!"

Masimo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MASI#NASDAQ">MASI</a>) has outperformed the market over the past 15 years by 2.29% on an annualized basis producing an average annual return of 14.41%. Currently, Masimo has a market capitalization of $8.92 billion. 
Buying $100 In MASI: If an investor had bought $100 of MASI stock 15 years ago, it would be worth $779.18 today based on a price of $165.03 for MASI at the time of writing.
<h3>Masimo's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1748902514_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

MASI

Here's How Much $100 Invested In Masimo 15 Years Ago Would Be Worth Today

Biotech

KURA

Kura Oncology And Kyowa Kirin Announce Phase 2 KOMET-001 Trial Results For Once-Daily Oral Menin Inhibitor Ziftomenib In Relapsed/Refractory NPM1-Mutated AML Showing 23% CR/CRh Rate, Durable MRD-Negative Responses Across Key Subgroups, Favorable Safety With Limited Myelosuppression At ASCO 2025

Couchbase (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BASE#NASDAQ">BASE</a>) has been analyzed by 4 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $18.5, along with a high estimate of $20.00 and a low estimate of $16.00. This current average represents a 14.63% decrease from the previous average price target of $21.67. 
<img src="https://www.benzinga.com/files/images/story/2025/1748901676_0.png" alt="price target chart" />
<h2>Deciphering Analyst Ratings: An In-Depth Analysis</h2>
The standing of Couchbase among financial experts becomes clear with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Blair Abernethy</td>
<td>Rosenblatt</td>
<td>Maintains</td>
<td>Buy</td>
<td>$20.00</td>
<td>$20.00</td>
</tr>
<tr>
<td>Brent Bracelin</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$16.00</td>
<td>$22.00</td>
</tr>
<tr>
<td>Sanjit Singh</td>
<td>Morgan Stanley</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$18.00</td>
<td>$23.00</td>
</tr>
<tr>
<td>Blair Abernethy</td>
<td>Rosenblatt</td>
<td>Announces</td>
<td>Buy</td>
<td>$20.00</td>
<td>-</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Couchbase. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Analysts unravel qualitative evaluations for stocks, ranging from 'Outperform' to 'Underperform'. These ratings offer insights into expectations for the relative performance of Couchbase compared to the broader market.</li>
<li>Price Targets: Analysts navigate through adjustments in price targets, providing estimates for Couchbase's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
To gain a panoramic view of Couchbase's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/BASE/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Couchbase analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">you can start by tracking it here</a>.
<h2>Unveiling the Story Behind Couchbase</h2>
Couchbase Inc provides a modern cloud database that offers the robust capabilities required for business-critical applications on a scalable and available platform. It empower developers and architects to build, deploy and run mission-critical applications. Couchbase delivers a high-performance, flexible and scalable modern database that runs across the data center and any cloud. Geographically, the company generates a majority of its revenue from the United States.
<h3>Couchbase: Delving into Financials</h3>
Market Capitalization Analysis: Reflecting a smaller scale, the company's market capitalization is positioned below industry averages. This could be attributed to factors such as growth expectations or operational capacity.
Positive Revenue Trend: Examining Couchbase's financials over 3M reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 9.65% as of 31 January, 2025, showcasing a substantial increase in top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Information Technology sector.
Net Margin: The company's net margin is below industry benchmarks, signaling potential difficulties in achieving strong profitability. With a net margin of -28.42%, the company may need to address challenges in effective cost control.
Return on Equity (ROE): Couchbase's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of -12.27%, the company may face hurdles in achieving optimal financial returns.
Return on Assets (ROA): Couchbase's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of -6.46%, the company may face hurdles in generating optimal returns from its assets.
Debt Management: With a below-average debt-to-equity ratio of 0.03, Couchbase adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>Understanding the Relevance of Analyst Ratings</h2>
Ratings come from analysts, or specialists within banking and financial systems that report for specific stocks or defined sectors (typically once per quarter for each stock). Analysts usually derive their information from company conference calls and meetings, financial statements, and conversations with important insiders to reach their decisions.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Analyst Ratings

BASE

Where Couchbase Stands With Analysts

IPOs

Press Releases

HCW Biologics Announces Pricing of $6.9 Million Registered Direct Offering and Concurrent Private Placement Priced Above Market Under NASDAQ Rules

HCW Biologics Inc. Received NASDAQ Staff Determination Letter

HCW Biologics' Founder and CEO to Address Opportunities and Challenges in Biomanufacturing for Cell and Gene Therapies During J.P. Morgan Week in San Francisco on January 15, 2025

Comments

HCW Biologics

Interés en corto

HCW Biologics (NASDAQ:HCWB) Bolsa, Informe de interés en corto

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL